Verrica Pharmaceuticals Inc. Quarterly Depreciation in USD from Q1 2019 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
Summary
Verrica Pharmaceuticals Inc. quarterly/annual Depreciation history and growth rate from Q1 2019 to Q2 2024.
  • Verrica Pharmaceuticals Inc. Depreciation for the quarter ending June 30, 2024 was $100K, unchanged year-over-year.
  • Verrica Pharmaceuticals Inc. annual Depreciation for 2023 was $530K, a 16.7% increase from 2022.
  • Verrica Pharmaceuticals Inc. annual Depreciation for 2022 was $454K, a 86.1% increase from 2021.
  • Verrica Pharmaceuticals Inc. annual Depreciation for 2021 was $244K, a 467% increase from 2020.
Depreciation, Quarterly (USD)
Depreciation, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2024 $100K $0 0% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-14
Q1 2024 $126K -$5K -3.82% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-13
Q2 2023 $100K Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-14
Q1 2023 $131K +$33K +33.7% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-13
Q1 2022 $98K +$87K +791% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-09
Q1 2021 $11K -$3K -21.4% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-09
Q1 2020 $14K +$3K +27.3% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-07
Q1 2019 $11K Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-07
* An asterisk sign (*) next to the value indicates that the value is likely invalid.